Bio-Thera Solutions Partners with Tabuk Pharmaceuticals to Commercialize BAT2206, a Stelara® (Ustekinumab) Biosimilar in Saudi Arabia ...Middle East

GUANGZHOU, China, Dec. 24, 2024 /PRNewswire/ -- Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and a pipeline of biosimilars, today announced the company has partnered with Tabuk Pharmaceutical Manufacturing...

Read More Details
Finally We wish PressBee provided you with enough information of ( Bio-Thera Solutions Partners with Tabuk Pharmaceuticals to Commercialize BAT2206, a Stelara® (Ustekinumab) Biosimilar in Saudi Arabia )

Also on site :

• LEGO Transforms Legendary Rock Band Into Custom Set
• Bryan Kohberger to plead guilty in Idaho killings to avoid execution
• One dead and two injured after stabbing attack at German company